Clinical trial Recruiting at 1 site Interventional Ages 3 to 9

Suprazygomatic Maxillary Nerve Block for Kids After Tonsil Removal

Official title: Opioid-Free Pediatric Tonsillectomy With Intraoperative Maxillary Nerve Block Via Suprazygomatic Injection (OPTIMaS): A Randomized Controlled Triple-Blinded Trial

Run by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · NCT07176533 · Data updated 2026-11-12

This study tests whether giving a SZMN nerve block with or without medicine can reduce pain after tonsil surgery in children.

Quick facts

Study typeInterventional
Ages3 Years to 9 Years
SexAll
Enrollment60 (estimated)
SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Academic / other
Locations1 site (London, Ontario)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedJune 30, 2027
Study endsJanuary 1, 2028
Registry record updatedSeptember 22, 2026
Trial IDNCT07176533 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 3-9 undergoing coblation intracapsillary tonsillectomy or adenotonsillectomy for sleep-disordered breathing.

Probably not a fit

Children who do not respond to regional nerve blocks or who have contraindications to the block may not experience pain reduction.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional trial in pediatric patients with sleep-disordered breathing will compare suprazygomatic maxillary nerve block using bupivacaine to a placebo, administered during coblation intracapsular tonsillectomy or adenotonsillectomy. The goal is to determine if the block lowers postoperative pain and improves recovery. Eligible participants are children aged 3 to 9 whose guardians can consent and who meet safety criteria; exclusions include allergies to local anesthetics, coagulopathy, certain congenital facial conditions, developmental disorders, and airway difficulties. The study is conducted at London Health Sciences Centre and associated institutions in London, Ontario.

Why it matters

Potential benefit: If successful, children could experience less postoperative pain and faster recovery after tonsil surgery.

How similar studies have gone: Previous adult studies suggest SZMN blocks can reduce facial pain after tonsil procedures; pediatric data are more limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients undergoing coblation intracapsular tonsillectomy or adenotonsillectomy for sleep apnoea.
2. Between 3-9 years old (inclusive).
3. Patient(s) and guardian(s) can consent to participate in the study.
4. Legal guardian(s) can read and write in English.

Exclusion Criteria:

1. Patient or legal guardian refusal to participate in the study.
2. Emergency surgery.
3. Allergies to local anesthetics.
4. Patients with coagulopathy.
5. Congenital facial abnormalities including (but not limited to) hemifacial microsomia, maxillary hypoplasia, Treacher-Collins syndrome, and Goldenhar syndrome.
6. Developmental delay or neurological impairment including (but not limited to) Trisomy 21, cerebral palsy, and autism spectrum disorder.
7. Previous airway surgery or a known or predicted airway difficulty.

Where it's running

  • Victoria Hospital, London Health Sciences Center, Western University
    London, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.